Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -9 of 9
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase III Compazine vs Methadone vs Tetrahydrocannabinol vs Placebo in Patients Receiving ADR for Malignant Neoplasms
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Supportive care
Completed
no age specified
MAYO-818304
NCCTG-818304, NCI-W82-1092, W82-1092
Last Modified:
5/23/2007
2.
Phase III Randomized, Double-Blind Study of Megestrol vs Dronabinol vs Both in Patients with Cancer-Related Anorexia and Cachexia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
18 and over
NCI
NCCTG-959255
NCI-P96-0075
3.
Phase III Antiemetic Therapy with Intramuscular Levonantradol vs Oral Tetrahydrocannabinol for Patients Receiving Antineoplastic Chemotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
18 and over
UMCC-8135
4.
Randomized Double-Blind Comparison of Metoclopramide vs Tetrahydrocannabinol to Control CACP-Induced Vomiting
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Supportive care
Closed
18 and over
MSKCC-8127
5.
Phase II Oral vs Rectal Tetrahydrocannabinol in the Treatment of CACP-Induced Nausea and Vomiting
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Closed
no age specified
NCI-D81-043-517
MDA-PC-8101
6.
Randomized Double-Blind Comparison of Tetrahydrocannabinol vs Haloperidol as Antiemetics for Cancer Patients Receiving Chemotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Closed
16 and over
NCI-D79-035-229
OSU-79HO156
7.
Effect of Dosage Level on Antiemetic Properties of Tetrahydrocannabinol in Cancer Patients with Chemotherapy-Induced Nausea and Vomiting
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Closed
over 18
NCI-D81-014-437
8.
Antiemetic Therapy with THC for Patients Undergoing Chemotherapy for Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Closed
21 to 65
UMCC-7903
9.
Randomized Comparison of Droperidol vs Tetrahydrocannabinol as Anti-Emetics in Patients with Gynecologic Malignancies Treated with CACP
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Completed
no age specified
NCI
GOG-51
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute